FDA Inspection 965141 — James Alexander Corp.

James Alexander Corp. — FEI 2242239

The FDA completed an inspection of James Alexander Corp. on Mar 31, 2016 in Blairstown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 31, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Blairstown, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.